Navigation Links
Florida Attorney Gary M. Farmer, Jr. Settles Third Whistleblower Drug Case for $1.27 Billion
Date:11/5/2013

FORT LAUDERDALE, Fla., Nov. 5, 2013 /PRNewswire/ -- South Florida consumer advocate and leading false claims attorney Gary M. Farmer, Jr., a partner with Farmer, Jaffe, Weissing, Edwards, Fistos & Lehrman, P.L., has successfully litigated his third major false claims case against a global pharmaceutical company. Today, the United States Department of Justice announced a settlement against pharmaceutical giant Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc. Johnson & Johnson and Janssen will pay a total of $2.2 billion to state and federal entities, $1.27 billion of which consists of civil fines and restitution regarding the drug Risperdal®. As the lead whistle-blower to bring the false claims to the government's attention, Farmer's client will share in a portion of the civil recovery.

Risperdal® was FDA approved for schizophrenia, specific bipolar disorders and behavior problems in teenagers and children with autism. The company was charged with:

  • Promoting and marketing the drug to physicians for use "off-label" in children and the elderly for conditions such as ADHD, depression and dementia;
  • Falsely claiming that Risperdal® was safer and more effective than similar, cheaper drugs; and
  • Failing to adequately warning about the drug's possible side effects (diabetes and neurological problems).

Using falsified and misleading science and data, Janssen marketed Risperdal for these and other unapproved uses, specifically targeting pediatricians and nursing homes to prey upon vulnerable children and the elderly. Not only did Janssen know about but failed to disclose significant health risks associated with Risperdal, it affirmatively misrepresented Risperdal as being safe and without these known dangers and side-effects.

"This case clearly showed how Janssen Pharmaceutical was willing to put profits before people, and sales before safety," said attorney Gary Farmer. "In the endless pursuit of profit Johnson & Johnson and Janssen aggressively marketed their drug Risperdal® with no regard as to what happened to patients who used it, including the most vulnerable patients – children and the elderly."

Whistleblower and client Vicki Starr approached Farmer regarding the illegal marketing practices of Risperdal® and filed suit under the Civil False Claims Act (31 U.S.C. Section 3729 et seq.). Also known as the Informer's Act, this statute allows private individuals to sue companies that knowingly defraud the U.S. and/or state governments. It also protects whistleblowers from demotion, suspension, harassment and discrimination for cooperating with the investigation of their employer. Starr not only witnessed this from the pharmaceutical perspective, as a former employee, but was also the target of the pharmaceutical company's marketing in her later employment as a medical director of a nursing home.

Farmer was also spearheaded a drug case against pharmaceutical giant, Eli Lilly, which was resolved in a record setting $1.42 billion settlement in January 2009. In 2010, he successfully settled another false claims case against AstraZeneca for $520 million in fines and restitution. Farmer is nationally-recognized as a civil justice attorney and consumer advocate and is considered one of Florida's leading consultants on qui tam law and litigation.

Farmer, Jaffe, Weissing, Edwards & Lehrman, P.L., a Fort Lauderdale Litigation firm, focuses on Consumer Class Actions, Personal Injury, Wrongful Death, and Whistleblower Suits (qui tam). The firm is headquartered at 425 N. Andrews Avenue, Suite 2 and may be reached at (800) 400-1098. Additional information about Gary Farmer or the firm may be obtained at http://www.pathtojustice.com or http://www.linkedin.com/pub/gary-farmer/13/863/b26 .

Contact
Gary Farmer - Farmer, Jaffe, Weissing, Edwards, Fistos & Lehrman, P.L.
(800) 400-1098


'/>"/>
SOURCE Farmer, Jaffe, Weissing, Edwards, Fistos & Lehrman, P.L.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research
2. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
3. Spine Pain Management Opens Two Additional Affiliate Diagnostic Centers in Florida
4. Floridas Stop-Sale System Achieves Significant Results In Battle Against Meth
5. Florida Cardiovascular Association Utilizes MedInformatix EMR Solution for Optimal Charting and Billing Workflow
6. Local Gastroenterologists First in South Florida to Offer Fecal Transplant
7. Bandages Plus, Inc. Doral, Florida has been acquired by The Morrissey Group, LLC
8. Florida Blue Awarded Certified Center of Excellence by BenchmarkPortal for Second Consecutive Year
9. Now Available in South Florida: CentraSight Treatment Program Offers New Hope for Patients with End-Stage Macular Degeneration
10. Only Podiatric Surgeon In S. Florida That Performs In-Office Ultrasound Imaging On Foot & Ankle Problems Saving Patients Over $1,000 In MRI Expenses & Extra Trip To Hospital
11. New Florida Peptides Site offering CJC-1295, GHRP-6, Sermorelin and more!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 2017 , ... Planet Fitness, one of the largest and fastest growing franchisors ... a flagship location in Covington, LA at 401 N. U.S. Highway 190, in January ... Office Depot in the Holiday Square shopping center. Its location allows it to serve ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... property taxes a year. In some states—like New York, New Jersey, Massachusetts, Texas, ... many overseas retirement havens have extremely low property-tax rates, which contributes to the ...
Breaking Medicine News(10 mins):